Continuing Medical Education Information
Target Audience
Endocrinologists, cardiologists, nephrologists, gastroenterologists/liver disease specialists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists.
Learning Objectives
By the end of the meeting, participants will be able to:
- Discuss the latest scientific and clinical discoveries in the field of endocrinology, diabetes and metabolism.
- Apply new found knowledge to the diagnosis and management of patients with disorders of endocrinology, diabetes or metabolism for improved patient outcomes.
- Assess the potential applications of emerging scientific advances that affect the practice of endocrinology.
- Explain to your patients the latest clinical treatment options in endocrine health.
Accreditation and Designation Statements
ACCME
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates this enduring material for a maximum of 86.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 86.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 86.75 contact hours.
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 86.75 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 86.75 contact hour(s) (8.675 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-21-2607-L01-P)
Type of Activity: Application
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 86.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Disclosure and Conflicts of Interest Policy:
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
AACE Annual Meeting Program Subcommittee
Chair, 2021 – Elizabeth Pearce, MD, MSc, FACEChair Elect, 2022 - Angela M. Leung, MD, MsC, ECNU
Vice Chair – Adriana G. Ioachimescu, MD, PhD, FACE
EC Liaison & President Elect - Felice A. Caldarella, MD, MBA, FACP, CDCES, FACE
Ex Officio, President – Howard M. Lando, MD, FACP, FACE
Ex Officio, Chair, Disease State Network Oversight Committee – Dace L. Trence, MD, MACE
Chair, Awards Task Force - Daniel L. Hurley, MD, FACE
Chair, Bone and Parathyroid - Robert A. Wermers, MD, FACE
Chair, Diabetes - Archana R. Sadhu, MD, FACE
Chair, Lipids and CV Health - Scott D. Isaacs, MD, FACP, FACE
Chair, Nutrition and Obesity – Monica Agarwal, MD, MEHP, FACE
Chair, Pituitary, Gonad, Adrenal and Neuroendocrine - Irina Bancos, MD
Chair, Thyroid - Sina Jasim, MD
Advisor - Christine L. Twining, MD, FACE
Chair, Education Oversight Committee – David C. Lieb, MD, FACE
Commercial Support
This activity is supported by educational grants from the following:
Bone and parathyroid session track
Radius Health, Inc.
Ultragenyx Pharmaceutical Inc.
Diabetes session track
Abbott Diabetes Care
Lilly
Medtronic
Pfizer-Merck Alliance
Zealand Pharma
Obesity session track
Rhythm Pharmaceuticals
Pituitary and adrenal disorders, gonad, and neuroendocrine session track
Chiasma, Inc.
Corcept Therapeutics
Strongbridge Biopharma
Thyroid session track
AbbVie
Disclosures
|
Name of Individual w/ Disclosed Financial Relationship |
Name of Commercial Interest Disclosed |
Nature of Relationship w/ the Commercial Interest |
|
Dr. Eliot Brinton, MD, FAHA, FNLA, FACE |
89bio, Alexion, Amarin, Dalcor, Esperion, Medicure, Regeneron |
Consulting Fees |
|
Alexion, Amarin, Esperion, Medicure, Kowa |
Honorarium |
|
|
Amarin, Kowa |
Research Support |
|
|
Dr. Silvio Inzucchi, MD |
Abbott, AstraZeneca, Boehringer Ingelheim, Esperion, Lexicon, Merck, Novo Nordisk, vTv Therapeutics |
Consulting Fees |
|
Boehringer Ingelheim |
Clinical Trial Publications Committee |
|
|
Novo Nordisk |
Clinical Trial Steering Committee |
|
|
AstraZeneca, Boehringer Ingelheim |
Clinical Trial Executive Committee |
|
|
Rodolfo Galindo, MD |
Abbott Diabetes, Eli Lilly, Novo Nordisk, Sanofi, Valeritas |
Consulting Fees |
|
Dexcom, Abbott Diabetes Care, Novo Nordisk |
Research Support |
|
|
Anne Peters, MD |
Abbott Diabetes Care, Dexcom, Insulet, Novo Nordisk |
Research grant |
|
Abbott Diabetes Care, Eli Lilly, Medscape, Novo Nordisk, Zealand |
Consulting Fees |
|
|
Eli Lilly |
Advisory Board |
|
|
Omada, Teladoc |
Ownership Interest |
|
|
Christie Ballantyne, MD, FACP, FACC |
Abbott Diagnostic, Althera, Amarin, Amgen, Arrowhead Phamaceital, Astre Zeneca, Corvidia, Denka Seiken, Esperion, Genentech, Gilead, Matinas BioPharma Inc., New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic, Sanofi-Synthelabo |
Consulting Fees |
|
Abbott Diagnostic, ADA, AHA, Akcea, Amgen, Esperion, NIH, Norvartis, Regeneron, Roche Diagnostic |
Research Grant |
|
|
Michael F. Holick, MD, PhD |
Abbott Inc., |
Honorarium |
|
Ontometrics Inc. |
Ownership Interest |
|
|
Carbogen Amcis |
University Grant |
|
|
Biogena Inc., Quest Diagnostics, Vital Choice Inc. |
Consulting Fees |
|
|
Jeff Mechanick, MD |
GoodSugar + |
Ownership Int. |
|
Abbott Nutrition International |
Honorarium |
|
|
Greg Forlenza, MD |
Beta Bionics, Dexcom, Eli Lilly, Insulet, Medtronic Diabetes, Tandem Diabetes |
Consulting Fees |
|
Abbott/AbbVie, Beta Bionics, Dexcom, Insulet, Medtronic Diabetes, Tandem Diabetes |
Research grant |
|
|
Kathleen Dungan, MD |
Abbott/AbbVie, Eli Lilly, Novo Nordisk, Sanofi Aventis |
Research grant |
|
Eli Lilly, Elsevier, Novo Nordisk, Tolerion |
Consulting Fees |
|
|
UpToDate, Cardiometabolic Health Conference |
Honorarium |
|
|
Robert Wermers, MD |
Alexion Pharmaceuticals, Inc. |
Research Grant |
|
Natalie Cusano, MD |
Radius, Shire/Takeda |
Consulting Fees |
|
Alexion, Shire/Takeda |
Honorarium |
|
|
Radius |
Research grant |
|
|
Richard Auchus, MD |
Adrenas, Corcept, Janssen, Omass Therapeutics, Orphagen Pharmaceuticals, Quest Diagnostics, Recordati Rare Diseases |
Consulting Fees |
|
Neurocrine, Novartis, Spruce Biosciences, Stonebridge |
Research grant |
|
|
Ken Cusi, MD |
Allergan Pharmaceuticals, AstraZeneca, Axcella Health, BMS, Boehringer Ingelheim, Coherus, Deuterex, Eli Lilly, Fractyl, Genentech, Genfit, Gilead Sciences, Janssen, Madrigal, Merck, Pfizer Pharmaceuticals, Poxel, Prosciento, Sanofi-Adventis, Viscera Labs |
Consulting Fees |
|
Cirius Therapeutics, Inc., Echosens, Inventiva, NIH, Nordic, Novo Nordisk, Novartis Pharmaceuticals Corporation, Zydus |
Research grant |
|
|
Fatmia Stanford, MD, MPH, MPA, FAAP, FACP, FAHA, FAMWA, FTOS |
Amazon |
Research Support |
|
Calibrate, GoodRx, Novo Nordisk |
Consulting Fees |
|
|
Angela Leung, MD, MSc, ECNU |
American Thyroid Association, IBSA Institut Biochimique SA |
Author/Editorial Board |
|
Medscape, Vertice Pharma |
Consulting Fees |
|
|
|
|
|
|
Monika Safford, MD |
Amgen |
Consulting Fees |
|
Michael R. McClung, MD, FACP, FACE, FASBMR |
Amgen |
Consulting Fees |
|
Amgen |
Honorarium |
|
|
Steven T. Harris, MD, FACP, FASBMR |
Amgen, Radius Health |
Consulting Fees |
|
Amgen, Radius Health |
Honorarium |
|
|
Mikhail Kosiborod, MD, FACC, FAHA |
Amgen, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi, Vifor Pharma |
Consulting Fees |
|
AstraZeneca, Boehringer Ingelheim, Novo Nordisk |
Honorarium |
|
|
AstraZeneca, Boehringer Ingelheim |
Research grant |
|
|
Adi Cohen, MD, MHS |
Amgen, Eli Lilly |
Research grant |
|
Gary Edelson, MD |
Amgen |
Honorarium |
|
Meryl LeBoff |
Amgen |
Ownership Interest |
|
Benjamin Leder, MD |
Amgen, Radius |
Consulting Fees |
|
Bart Clarke, MD |
Ascendis, Inc., Chugai Pharmaceutials, Takeda |
Research grant |
|
Rashmi Mullur, MD |
Ascensia Diabetes Care |
Royalties |
|
Guillermo Umpierrez, MD, CDE |
Astra Zeneca, Dexcom, Novo Nordisk |
University Grant |
|
Steve Nissen, MD |
Astra Zeneca, Novo Nordisk |
Reearch Support |
|
Dror Dicker, MD |
AstraZeneca, Boehringer Ingelheim, Novo Nordisk |
Consulting Fees |
|
Boehringer Ingelheim, Novo Nordisk, Eli Lilly |
Research Grant |
|
|
AstraZeneca, Boehringer Ingelheim, Novo Nordisk |
Honorarium |
|
|
Lance Sloan, MD, MSE, FACE, FASN, FACP |
AstraZeneca, Boehringer Ingelheim, Janssen |
Consulting Fees |
|
AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen |
Honorarium |
|
|
Ildiko Lingvay, MD, MPH, MSCS |
AstraZeneca, Boehringer Ingelheim, Janssen, Bayer, Eli Lilly, Intarcia, Intecept, Mannkind, Merck, Novon Nordisk, Pfizer, Sanofi, TARGETPharma, Valeritas, Zealand |
Consulting Fees |
|
Boehringer Ingelheim, Merck, Novo Nordisk, Pfizer, Sanofi |
Research Grant |
|
|
Mylan |
Contracted Research |
|
|
Fida Bacha, MD, FAAP |
Takeda |
University Grant |
|
AstraZeneca |
Research Support |
|
|
Janet McGill, MD, MA |
Bayer, Boehringer Ingelheim,Dexcom, Salix |
Consulting Fees |
|
Dexcom, Medtronic, Novo Nordisk |
Research Grant |
|
|
Dexcom, Medtronic |
University Grant |
|
|
Michael Tuttle, MD |
Bayer, Eisai, Veracyte |
Consulting Fees |
|
Steven Russel, MD |
Beta Bionics, Convatec, Eli Lilly Diabetes, Novo Nordisk, Senseonics |
Consulting Fees |
|
Novo Nordisk |
Honorarium |
|
|
Jennifer Sherr, MD, PhD |
Bigfoot biomedical, Cecelia Health, Eli Lilly, Insulet Corporation, Medtronic Diabetest |
Consulting Fees |
|
Dexcom, Medtronic |
Research Support |
|
|
Eli Lilly, Insulet Corporation, Medtronic Diabetes |
Contracted Research |
|
|
Lexicon, Sanofi, Insulet, Eli Lilly, Medtronic |
Honorarium |
|
|
Arya Sharma, MD |
Boehringer Ingelheim/Eli Lilly, Novo Nordisk |
Consulting Fees |
|
Boehringer Ingelheim, Novo Nordisk |
Honorarium |
|
|
Rachel Pessah-Pollack, MD, FACE |
Boehringer Ingelheim, Radus |
Consulting Fees |
|
Health Monitor, Medscape |
Honorarium |
|
|
Professor Luca Busetto, MD |
Bruno farmaceutici |
Honorarium |
|
Novo Nordisk |
Consulting Fees |
|
|
Maria Fleseriu, MD, FACE |
Chiasma, Crinetics, Inois, Novartis, Recordati |
University Grants/Research Support |
|
Chiasma, Crinetics, Ionis, Ispen, Novartis, Pfizer, Recordati |
Honorarium |
|
|
Chiasma, Crinetics, Ionis, Ispen, Novartis, Pfizer, Recordati |
Consulting Fees |
|
|
Diane Donegan, MD |
Corcept |
Contracted Research |
|
Corcept |
Consulting Fees |
|
|
Mouhammed Amir Habra, MD |
Exelixix, Corcept |
Research Grant |
|
Corcept, HRA Pharma |
Honorarium |
|
|
Anand Vaidya, MD, MMSc |
Corcept Therapeutics, HRA Pharma, Mineralys |
Consulting Fees |
|
Amisha Wallia, MD |
Eli Lilly,Novo Nordisk, United Health Group |
Research Grant |
|
Marie McDonnell, MD |
Eli Lilly |
Research Support |
|
Everlywell Inc |
Consulting Fees |
|
|
Vijay Shivaswamy, MD |
Eli Lilly, Kowa Pharmaceuticals, Novo Nordisk |
Research Grant |
|
Francesco Rubino, MD |
Ethicon |
Honorarium |
|
GI Dynamics, Medtrnic, Novo Nordisk |
Consutling Fees |
|
|
Ethicon, Medtronic |
Research Grant |
|
|
Shanu Kothari, MD |
Ethicon, Gore, Medtronic |
Honorarium |
|
Ted Kyle, RPh, MBA |
Gelesis, Novo Nordisk |
Consulting Fees |
|
Gelesis, Novo Nordisk |
Contracted Research |
|
|
Nutrisystem, Gelesis, Novo nordisk |
Honorarium |
|
|
Gelesis |
Research Grant |
|
|
Novo Nordisk, Nutrisystem, Gelesis |
Research Support |
|
|
Richard Pratley, MD |
Novo Nordisk |
Honorarium |
|
Merck, Novo Nordisk, Pfizer, Sanofi, Scohia Pharma Inc, Sun Pharmaceutical Industries |
Consulting Fees |
|
|
Hammi Pharmaceutical Co., Metavention, Novo Nordisk, Poxel SA |
Research Grant |
|
|
Alex Tessnow, MD |
Horizon, Sanofi |
Consulting Fees |
|
Marius Stan, MD |
Horizon Pharma, Immunovant |
University Grant |
|
Irina Bancos, MD |
HRA Pharma, Sparrow Pharmaceutics |
Consulting Fees |
|
Tait Shanafelt, MD * Keynote Speaker |
Mayo Clinic |
Honorarium |
|
Mayo Clinic |
Royalties |
|
|
Shivani Agarwal, MD, MPH |
Medtronic |
Consulting Fees |
|
Prof George Grunberger, MD, FACP, MACE |
Medtronic |
Contracted Research |
|
Slman Razvi, MD, FRCP |
Medtronic |
Honorarium |
|
Sandra Weber, MD, FACP, FACE |
NIH |
Grant/Research Reprot |
|
NIH |
Research Grant |
|
|
Dr. Dace L. Trence, MD, FACE |
Medtronic |
Stockholder/Ownership Interest |
|
Sanofi |
Stockholder/Ownership Interest |
|
|
Dr. Ian DeBoer, MD |
AstraZenca, Bayer, Boehringer Ingelheim, Cyclerion Therapeutics, George Clinical, Goldfinch Bio |
Consulting Fees |
|
DexCom |
Research Support |
|
|
Dr. Marconi Abreu, MD |
Tandem Diabetes |
Spouse - Diabetes Educator/Salary |
|
Adriana G. Ioachimescu, MD, PhD, FACE |
Chiasma, Crinetics, Pfizer, Recordati, Stonebridge, Tiburio |
Consulting Fees |
|
Chiasma, Pfizer, Recordati, Novartis, Stonebridge |
Research Grant |
|
|
Chiasma, Crinetics, Pfizer, Recordati, Stonebridge |
Pending grants |
|
|
W. Timothy (Tim) Garvey, MD |
Eli Lilly, Epitome, Novo Nordisk, Pfizer |
University Grants/Research Support |
|
Dr. Bartolome Burguera, MD, PhD |
Novo Nordisk |
Honorarium, Consulting Fees, Research Grant |
|
Robert Kushner, MD |
Novo Nordisk, Weight Watchers |
Consulting Fees, Honorarium |
|
Gary Lewis, MD |
Amgen Canada |
Consulting Fees |
All other speakers, planners, reviewers, editors, and staff who control content have no relevant financial relationships to disclose.